Dissociation between cardiometabolic markers and symptom severity in restless legs syndrome: A retrospective case-control study
Restless legs syndrome (RLS) has been associated with adverse cardiometabolic features, but whether these abnormalities independently characterize RLS or relate to symptom severity remains uncertain. This study evaluated lipid-derived cardiometabolic markers, including the atherogenic index of plasma (AIP), and the atherosclerotic cardiovascular disease (ASCVD) score in RLS and examined their relationships with symptom severity. This retrospective case-control study included 110 patients with RLS and 100 non-RLS controls. Analyses included unadjusted comparisons, false discovery-rate-corrected correlations with the International Restless Legs Syndrome Rating Scale (IRLS), multivariable regression, body mass index (BMI)-adjusted robust models, RLS subtype analyses, and an age-restricted ASCVD sensitivity analysis. An additional exploratory IRLS model included recorded treatment category and RLS subtype. In unadjusted comparisons, patients with RLS had higher BMI, triglycerides, AIP, triglyceride/high-density lipoprotein ratio, Castelli indices, C-reactive protein, systolic blood pressure, and exploratory full-sample ASCVD scores and lower ferritin. However, differences in AIP and the other lipid-derived indices were no longer significant after BMI adjustment (all P ≥ .102). No statistically significant correlation between a lipid-derived index and IRLS was detected. Disease duration showed a strong correlation with severity (rho = 0.674, P < .001). The ferritin association was attenuated after subtype adjustment (P = .091) but was significant in the exploratory treatment category and subtype-adjusted model (P = .001); AIP remained nonsignificant in that model (B=-2.320; 95% confidence interval, -4.958-0.318; P = .084). Age-restricted ASCVD analyses detected no statistically significant group difference or association with IRLS. Crude lipid-index differences were attenuated after BMI adjustment, and statistically significant lipid-severity associations were not detected. Disease duration remained associated with symptom burden, whereas ferritin findings varied across models. Treatment exposure, subtype heterogeneity, and imprecision limit inference; nonsignificant results do not establish absence of an association. These findings do not establish lipid-derived indices or ASCVD as stand-alone diagnostic or severity markers for RLS.
Authors
- Elif Simin Issı (ORCID: https://orcid.org/0000-0003-1950-9141)
- Elif Topay (ORCID: https://orcid.org/0009-0001-1772-2048)
Institutions
- Afyonkarahisar Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Medicine
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1097/md.0000000000051579
- Primary Topic
- Restless Legs Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00